|
||
Report |
Correspondence to Susan E. LaFlamme: laflams{at}mail.amc.edu
|
|
|---|
| Introduction |
|---|
|
|
|---|
| Results and discussion |
|---|
|
|
|---|
IIb-5ß3-1 heterodimeric chimeric integrin. These chimeras contain the extracellular and transmembrane domain of the
IIbß3 fibrinogen (Fg) receptor connected to the tails of the
5ß1 fibronectin (Fn) receptor (Fig. 1 A), allowing CHO cell adhesion to Fg (Ylanne et al., 1993).
We isolated the function of the recombinant chimeras by adhering cells to Fg in the serum-free growth medium CCM1 that does not support CHO cell proliferation in the absence of a preexisting matrix (unpublished data). WT cells showed robust proliferation on Fg in CCM1, whereas CHO K1 and Y783A cells proliferated poorly (Fig. 1 B). CCM1 similarly promoted proliferation of Y783A and CHO K1 cells on Fn (Fig. 1 B). Furthermore, infection of Y783A cells with an adenovirus that directed the expression of the ß3-1 chimeric subunit containing the WT ß1 tail restored cell proliferation of Y783A cells (unpublished data). Although Y783A cells show slow adhesion kinetics on Fg (Fig. S1 A, available at http://www.jcb.org/cgi/content/full/jcb.200603069/DC1), most cells adhere and spread by 3 h (Fig. S1 B). Thus, the defect in proliferation is not simply due to a lack of adhesion.
|
The poor proliferation of the Y783A cells was accompanied by accumulation of bi- and multinucleated cells (Fig. 1 E). Analysis of the binucleation kinetics revealed a uniform increase in the nuclei per cell in Y783A cells with no significant change in WT cells (Fig. 1 F). Because the most likely explanation was a defect in cytokinesis, we examined this process by time-lapse microscopy. After rounding at mitosis, WT cells completed cleavage furrow ingression within 510 min and cytokinesis within 2030 min (unpublished data). In contrast, most Y783A cells attempting cytokinesis showed cleavage furrow regression and cytokinesis failure. This phenotype was suppressed when Y783A cells were adhered to Fn (Fig. 1, G and I). Quantification of cytokinesis attempts and successes during the first cell cycle on Fg in CCM1 indicated that
90% of the WT cells attempted and successfully completed cytokinesis within 1620 h (Fig. 1, H and I). A significant percentage of Y783A cells attempted cytokinesis, but most failed to divide (Fig. 1, H and I). Many Y783A cells showed a partially constricted cleavage furrow changing in diameter through an extended period of time and finally regressing to produce binucleated cells. In those few cases where cleavage furrow ingression was completed, midbody formation and/or daughter separation was significantly delayed or inhibited (unpublished data). As expected, Y783A cells successfully completed cytokinesis under the same conditions that promoted their proliferation (Fig. 1 H). Together, our data indicate that the Y783A mutation inhibits the successful completion of cytokinesis.
To gain mechanistic insight, we compared the actin and MT cytoskeletons in mitotic WT and Y783A cells that had proliferated on Fg in CCM1 for 1518 h (a time of peak in cytokinesis attempts; Fig. 1 H). Cells at prometaphase/metaphase were identified by their round morphology and the presence of condensed chromosomes. At this stage, the majority of WT cells (85%) formed functional bipolar spindles, as judged by
- and
-tubulin distribution and chromosome congression at the equatorial plane (Fig. 2 A).
In contrast, most Y783A cells showed random distributions of chromosomes and multipolar spindles or no evidence of spindle assembly (Fig. 2 A). As expected, Y783A cells formed functional bipolar spindles on Fn (Fig. 2 B). At anaphase, WT cells showed normal contractile rings and chromosome segregation (Fig. 2 C); in contrast, most Y783A cells showed evidence of multiple contractile rings and a lack of chromosome segregation consistent with the presence of aberrant spindles (Fig. 2 C, middle). The few Y783A cells that were able to segregate chromosomes (Fig. 2 C, right) exhibited abnormalities at telophase (Fig. S2, available at http://www.jcb.org/cgi/content/full/jcb.200603069/DC1). Collectively, our data strongly suggest that the Y783A mutation inhibits cytokinesis by preventing the formation of a normal bipolar spindle.
|
The Y783A mutation in the ß1 tail is known to inhibit the expression of the high-affinity conformation of
IIb-5ß3-1 in CHO cells (O'Toole et al., 1995). Therefore, we tested whether LIBS6, a specific activating antibody for
IIbß3 (Frelinger et al., 1991), could prevent the mutant phenotypes in Y783A cells. In control experiments, LIBS6 activated the Y783A chimeric integrin (unpublished data) and promoted rapid adhesion and spreading of Y783A cells on Fg (Fig. S1 D). Importantly, LIBS6 rescued the assembly of a radial MT network (Fig. 3, A and B), MT regrowth from centrosomes at interphase (Fig. 3, C and D) and spindle poles at mitosis (Fig. 3, E and F), the assembly of a bipolar spindle (Fig. 3, I and J), and cytokinesis (Fig. 3, G and H; and Videos 13, available at http://www.jcb.org/cgi/content/full/jcb.200603069/DC1).
In agreement with these results, LIBS6 also prevented binucleation (unpublished data).
|
IIb-L deletion (
IIb-L
) with the ß3-1(Y783A) chimeric subunit resulted in a constitutively active integrin (Fig. S2, DF) and rescued MT regrowth (Fig. 4), as observed with LIBS6.
In addition, coexpression of a ß3-1 subunit containing an N780A mutation in the NPIY motif (ß3-1[N780A]) with the
IIb-5 subunit prevented soluble Fg binding (Fig. S2, DF) and inhibited MT regrowth (Fig. 4), mimicking the effects of the Y783A mutation. Thus, the inhibition and rescue of MT regrowth are not specific to the Y783A mutation and the LIBS6 activating antibody.
|
IIb-5ß3-1, we generated GD25 cell lines (ß1-null; Fässler et al., 1995) expressing full-length human ß1 containing either the WT (GD25 h-ß1WT) or the Y783A mutant tail (GD25 h-ß1Y783A; Fig. 5 A).
In contrast, to the GD25 h-ß1WT cells, MT regrowth from interphase centrosomes was inhibited in GD25 h-ß1Y783A cells adhered to laminin-1 (Lm). Moreover, this phenotype was suppressed by TS2/16 (Masumoto and Hemler, 1993), a specific ß1-activating antibody (Fig. 5, B and C). In addition, when these cells were mitotically arrested and replated on Lm, WT but not Y783A cells formed a normal bipolar spindle (Fig. 5, D and E). Thus, the effects of the Y783A mutation are not cell-type or integrin specific.
|
MT dynamics are under tight and complex control throughout the cell cycle. At interphase, the organization of the MT network requires the regulation of MT nucleation, growth, and anchorage at the centrosome and the association of MTs with the cell cortex. The assembly of the bipolar spindle at mitosis also requires the regulation of kinetochore-associated MTs, as well as centrosome duplication and cohesion (Doxsey, 2001; Gadde and Heald, 2004; Kline-Smith and Walczak, 2004; Maiato et al., 2004). The Y783A mutation may inhibit the activity of one or more of the proteins that regulate these events. The goal of future studies will be to identify the aspects and targets of integrin function required for spindle assembly and cytokinesis.
| Materials and methods |
|---|
|
|
|---|
5 x 104 cells were replated in CCM1 in 24-well dishes on 15 µg/ml Fg/Fn (CHO cells) or 30 µg/ml Lm (GD25 cells) and processed as described in the figure legends.
Cell proliferation assays
Serum-starved cells were replated onto either Fg- or Fn-coated (15 µg/ml) 12-well dishes (3 x 103 cells/well, in triplicate), fixed at the indicated times in 3.7% paraformaldehyde, and stained with crystal violet (0.5% in 20% methanol) for 1 h at room temperature. Incorporated dye was extracted with 1% SDS and quantified by measuring A598 in a spectrophotometer. To assay DNA synthesis, serum-starved cells and serum-starved cells replated on Fg in CCM1 for 5 h were supplemented with BrdU for 18 h. Cells positive for BrdU incorporation were quantified by microscopy.
MT regrowth
Serum-starved cells (
5 x 104) were replated on 15 µg/ml of either Fg or Fn (CHO cells) or on 30 µg/ml Lm (GD25 cells) in CCM1. 314 h after plating, cells were treated with 10 µg/ml nocodazole (Calbiochem) for 2 h at 4°C, washed with cold PBS to remove the drug, allowed to nucleate MTs for 515 min in warmed CCM1 ± LIBS6 (CHO cells) or TS2/16 (GD25 cells), and processed for immunofluorescence microscopy.
Time-lapse microscopy
Serum-starved cells were replated (24-well dishes) on Fg or Fn in CCM1 supplemented with 10 mM Hepes, pH 7.4. 3 h after seeding, when most cells were fully spread, dishes were transferred to a microscope equipped with a heated (37°C) chamber, and phase-contrast images were recorded (12 frames/h) during the first cell cycle (1620 h). Multiple fields (three per sample) were analyzed using a rotary stage and 20x objective. Where indicated, cells were arrested at metaphase by nocodazole treatment, isolated, replated on Fn or Fg in CCM1 ± LIBS6, and imaged as before but at 2 frames/min to analyze cytokinesis in greater detail.
Immunofluorescence microscopy
Cells were permeabilized for 30 s in 80 mM Pipes, pH 6.8, 5 mM EGTA, 1 mM MgCl2, and 0.5% Triton X-100; fixed for 10 min in the same buffer containing 5% glutaraldehyde; and incubated for 7 min in 1% sodium borohydrate in PBS. To coanalyze MTs and F-actin, cells were fixed in 3.7% paraformaldehyde and 1% sucrose in PBS for 5 min, permeabilized in PBS and 0.5% Triton X-100 for 10 min, and processed for immunostaining as glutaraldehyde-fixed cells (excluding the glutaraldehyde-quenching step). The following antibodies were used:
-tubulin (mouse mAb DM1A; Sigma-Aldrich),
-tubulin (rabbit AK-15; Sigma-Aldrich), Alexa Fluor 488conjugated goat anti-mouse (Invitrogen), and Alexa Fluor 594conjugated goat anti-rabbit (Invitrogen). F-actin was analyzed with Alexa Fluor 594conjugated Phalloidin (1:300 dilution), and DNA was stained with 1 µM of either Hoechst 33342 or DAPI (Invitrogen). Samples were analyzed using an inverted microscope (TE2000-E; Nikon) equipped with phase contrast and epifluorescence, a digital camera (CoolSNAP HQ; Roper Scientific), a Ludl rotary encoded stage, 37°C incubator, and MetaVue (Molecular Devices) and AutoQuant deconvolution software (AutoQuant Imaging, Inc.).
Western blotting
Protein expression was analyzed by Western blotting using the following commercially available antibodies:
-tubulin (mouse mAb DM1A), cyclin D1 (mouse mAb DCS-6; BD Biosciences), Pan ERK (mouse mAb 16; BD Biosciences), and cyclin B1 (mouse mAb GNS1; Santa Cruz Biotechnology, Inc.). Blots were stripped and reprobed with the indicated antibodies for loading controls.
Online supplemental material
The supplemental text provides information relating to the generation of chimeric integrins and stable cell lines. Fig. S1 shows the adhesion and spreading of WT and Y783A cells on Fg in CCM1, expression levels of
-tubulin and chimeric integrins under these conditions, and the promotion of rapid adhesion and spreading of Y783A cells on Fg by LIBS6. Fig. S2 shows the characteristic telophase phenotypes in these cells under similar conditions (S2A-C), as well as the characterization of the ability of CHO cells transiently expressing WT and mutant chimeric integrins to bind soluble and immobilized Fg (S2D-G). Videos 1 and 2 show the completion and failure of the cytokinesis in WT and Y783A cells, respectively, on Fg in CCM1. Videos 3 and 4 show the rescue of cytokinesis in Y783A cells on Fn or on Fg when treated with LIBS6, respectively. Online supplemental material is available at http://www.jcb.org/cgi/content/full/jcb.200603069/DC1.
| Acknowledgments |
|---|
IIb, ß3, and
IIb-L
expression vectors and the LIBS6 antibody; Dr. S. Blystone for the 7G2 antibody; Dr. R. Fässler for the GD25 cells; Dr. Y. Takada for human ß1 cDNA; Drs. J. Sottile, A. Khodjakov, and Dr. K.M. Yamada for critically reading this manuscript; and Dr. A. Khodjakov for advise in imaging MTs. This work was supported by National Institutes of Health grants GM51540 (to S.E. LaFlamme) and T32-HL07194 (to C.G. Reverte) and by the American Heart Association postdoctoral fellowship 0525875T (to C.G. Reverte).
Submitted: 14 March 2006
Accepted: 10 July 2006
| References |
|---|
|
|
|---|
Assoian, R.K., and M.A. Schwartz. 2001. Coordinate signaling by integrins and receptor tyrosine kinases in the regulation of G1 phase cell-cycle progression. Curr. Opin. Genet. Dev. 11:4853.[CrossRef][Medline]
Aszodi, A., E.B. Hunziker, C. Brakebusch, and R. Fässler. 2003. Beta1 integrins regulate chondrocyte rotation, G1 progression, and cytokinesis. Genes Dev. 17:24652479.
Ben-Ze'ev, A., and A. Raz. 1981. Multinucleation and inhibition of cytokinesis in suspended cells: reversal upon reattachment to a substrate. Cell. 26:107115.[CrossRef][Medline]
Bodeau, A.L., A.L. Berrier, A.M. Mastrangelo, R. Martinez, and S.E. LaFlamme. 2001. A functional comparison of mutations in integrin beta cytoplasmic domains: effects on the regulation of tryosine phosphorylation, cell spreading, cell attachment and beta1 integrin conformation. J. Cell Sci. 114:27952807.
Doxsey, S. 2001. Re-evaluating centrosome function. Nat. Rev. Mol. Cell Biol. 2:688698.[CrossRef][Medline]
Fässler, R., M. Pfaff, J. Murphy, A.A. Noegel, S. Johansson, R. Timpl, and R. Albrecht. 1995. Lack of ß1 integrin gene in embryonic stem cells affects morphology, adhesion, and migration but not integration into the inner cell mass of blastocysts. J. Cell Biol. 128:979988.
Frelinger, A.L., III, X.P. Du, E.F. Plow, and M.H. Ginsberg. 1991. Monoclonal antibodies to ligand-occupied conformers of integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) alter receptor affinity, specificity, and function. J. Biol. Chem. 266:1710617111.
Fry, A.M., P. Meraldi, and E.A. Nigg. 1998. A centrosomal function for the human Nek2 protein kinase, a member of the NIMA family of cell cycle regulators. EMBO J. 17:470481.[CrossRef][Medline]
Gadde, S., and R. Heald. 2004. Mechanisms and molecules of the mitotic spindle. Curr. Biol. 14:R797R805.[CrossRef][Medline]
Geiger, B., A. Bershadsky, R. Pankov, and K.M. Yamada. 2001. Transmembrane crosstalk between the extracellular matrixcytoskeleton crosstalk. Nat. Rev. Mol. Cell Biol. 2:793805.[CrossRef][Medline]
Glotzer, M. 2001. Animal cell cytokinesis. Annu. Rev. Cell Dev. Biol. 17:351386.[CrossRef][Medline]
Hynes, R.O. 2002. Integrins: bidirectional, allosteric signaling machines. Cell. 110:673687.[CrossRef][Medline]
Kline-Smith, S.L., and C.E. Walczak. 2004. Mitotic spindle assembly and chromosome segregation: refocusing on microtubule dynamics. Mol. Cell. 15:317327.[CrossRef][Medline]
Maddox, A.S., and K. Burridge. 2003. RhoA is required for cortical retraction and rigidity during mitotic cell rounding. J. Cell Biol. 160:255265.
Maiato, H., C.L. Rieder, and A. Khodjakov. 2004. Kinetochore-driven formation of kinetochore fibers contributes to spindle assembly during animal mitosis. J. Cell Biol. 167:831840.
Masumoto, A., and M.E. Hemler. 1993. Multiple activation states of VLA-4. Mechanistic differences between adhesion to CS1/fibronectin and to vascular cell adhesion molecule-1. J. Biol. Chem. 268:228234.
Orly, J., and G. Sato. 1979. Fibronectin mediates cytokinesis and growth of rat follicular cells in serum-free medium. Cell. 17:295305.[CrossRef][Medline]
O'Toole, T.E., Y. Katagiri, R.J. Faull, K. Peter, R. Tamura, V. Quaranta, J.C. Loftus, S.J. Shattil, and M.H. Ginsberg. 1994. Integrin cytoplasmic domains mediate inside-out signal transduction. J. Cell Biol. 124:10471059.
O'Toole, T.E., J. Ylanne, and B.M. Culley. 1995. Regulation of integrin affinity states through an NPXY motif in the beta subunit cytoplasmic domain. J. Biol. Chem. 270:85538558.
Tadokoro, S., S.J. Shattil, K. Eto, V. Tai, R.C. Liddington, J.M. de Pereda, M.H. Ginsberg, and D.A. Calderwood. 2003. Talin binding to integrin beta tails: a final common step in integrin activation. Science. 302:103106.
Vandre, D.D., P. Kronebusch, and G.G. Borisy. 1984. The interphase-motisis transition: microtubule rearrangements in cultured cells and sea urchin eggs. In Molecular Biology of the Cytoskeleton. G.G. Borisy, D.W. Cleveland, and D.B. Murphy, editors. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 316.
Winklbauer, R. 1986. Cell proliferation in the ectoderm of the Xenopus embryo: development of substratum requirements for cytokinesis. Dev. Biol. 118:7081.[CrossRef][Medline]
Ylanne, J., Y. Chen, T.E. O'Toole, J.C. Loftus, Y. Takada, and M.H. Ginsberg. 1993. Distinct functions of integrin
and ß subunit cytoplasmic domains in cell spreading and formation of focal adhesions. J. Cell Biol. 122:223233.
Related Article
This article has been cited by other articles:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|